220 related articles for article (PubMed ID: 31526292)
1. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
4. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
Tian F; Ying HM; Wang YY; Cheng BN; Chen J
Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
[TBL] [Abstract][Full Text] [Related]
5. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
7. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
8. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
[TBL] [Abstract][Full Text] [Related]
9. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J
J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
Cai H; Jiang Z; Yang X; Lin J; Cai Q; Li X
Endocr J; 2020 Apr; 67(4):397-408. PubMed ID: 31875589
[TBL] [Abstract][Full Text] [Related]
11. Enhanced alleviation of insulin resistance via the IRS-1/Akt/FOXO1 pathway by combining quercetin and EGCG and involving miR-27a-3p and miR-96-5p.
Liu H; Guan H; Tan X; Jiang Y; Li F; Sun-Waterhouse D; Li D
Free Radic Biol Med; 2022 Mar; 181():105-117. PubMed ID: 35124182
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W
Int J Mol Med; 2019 Jan; 43(1):345-357. PubMed ID: 30431065
[TBL] [Abstract][Full Text] [Related]
13. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance.
Song Y; Wu L; Li M; Xiong X; Fang Z; Zhou J; Yan G; Chen X; Yang J; Li Y
EBioMedicine; 2019 Apr; 42():494-503. PubMed ID: 30948354
[TBL] [Abstract][Full Text] [Related]
15. Statin suppresses sirtuin 6 through miR-495, increasing FoxO1-dependent hepatic gluconeogenesis.
Shi MY; Bang IH; Han CY; Lee DH; Park BH; Bae EJ
Theranostics; 2020; 10(25):11416-11427. PubMed ID: 33052223
[No Abstract] [Full Text] [Related]
16. MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4.
Li K; Zhang J; Yu J; Liu B; Guo Y; Deng J; Chen S; Wang C; Guo F
J Biol Chem; 2015 Mar; 290(13):8185-95. PubMed ID: 25657009
[TBL] [Abstract][Full Text] [Related]
17. Delivery of muscle-derived exosomal miRNAs induced by HIIT improves insulin sensitivity through down-regulation of hepatic FoxO1 in mice.
Castaño C; Mirasierra M; Vallejo M; Novials A; Párrizas M
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30335-30343. PubMed ID: 33199621
[TBL] [Abstract][Full Text] [Related]
18. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
[TBL] [Abstract][Full Text] [Related]
19. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK).
Sun WX; Lou K; Chen LJ; Liu SD; Pang SG
J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
